|本期目录/Table of Contents|

[1]罗来敏,杨柳,鄢杰.国产SM160H高通量透析器有效性和安全性验证临床试验[J].福建医科大学学报,2017,51(05):339-341.
点击复制

国产SM160H高通量透析器有效性和安全性验证临床试验(PDF)
分享到:

《福建医科大学学报》[ISSN:1672-4194/CN:35-1192/R]

卷:
第51卷
期数:
2017年05期
页码:
339-341
栏目:
经验介绍
出版日期:
2017-10-30

文章信息/Info

Title:
-
文章编号:
16724194(2017)05033903
作者:
罗来敏1 杨柳1 鄢杰2
作者单位: 1.南昌大学 第一附属医院肾内科,南昌330006; 2. 江西三鑫医疗科技股份有限公司 法规注册部,南昌330002
Author(s):
-
关键词:
肾透析 砜类 透析仪器和设备
Keywords:
-
分类号:
R459.5
DOI:
-
文献标志码:
B
摘要:
-
Abstract:
-

参考文献/References:

[1]Nitta K. Chronic kidney diseasesrecent advances in clinical and basic research[J]. Contributions to Nephrology, 2015,185:ⅦⅪ.
[2]Brandt T, Wiese F. Physical and chemical characteristics of different polyethersulfone membranes[J]. Contributions to Nephrology, 2003,138:112.
[3]国家食品药品监督管理总局. 一次性使用透析器产品注册技术审查指导原则[S]. 北京:国家食品药品监督管理总局网站,2013.
[4]Foundation N K. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update[J]. Am J Kidney Dis, 2015,66(5):884930.
[5]Barzegar H, Moosazadeh M, Jafari H, et al. Evaluation of dialysis adequacy in hemodialysis patients: a systematic review[J]. Urology Journal, 2016,13(4):27442749.
[6]王质刚. 血液净化学[M]. 3版. 北京:北京科学技术出版社, 2010:33.
[7]SameiroFaria M D, Ribeiro S, Costa E, et al. Risk factors for mortality in hemodialysis patients: twoyear followup study[J].Disease Markers, 2013, 35(6):791798.
[8]Karkar A. Modalities of hemodialysis: quality improvement[J]. Saudi Journal of Kidney Diseases & Transplantation An Official Publication of the Saudi Center for Organ Transplantation Saudi Arabia, 2012,23(6):11451161.
[9]Topciu|Shufta V, Miftari R, Haxhibeqiri V, et al. Association of beta2 microglobulin with inflammation and dislipidemia in highflux membrane hemodialysis patients[J]. Medical Archives, 2016, 70(5):348350.
[10]Kokubo K, Kurihara Y, Kobayashi K, et al. Evaluation of the biocompatibility of dialysis membranes[J]. Blood Purification, 2015,40(4):293297.
[11]Bossola M, Sanguinetti M, Scribano D, et al. Circulating bacterialderived DNA fragments and markers of inflammation in chronic hemodialysis patients[J]. Clinical Journal of the American Society of Nephrology Cjasn, 2009,4(2):379385.
[12]Adejumo O A, Okaka E I, Okwuonu C G, et al. Serum Creactive protein levels in predialysis chronic kidney disease patientsin southern Nigeria[J]. Ghana Medical Journal, 2016, 50(1):3138.
[13]徐斌, 张文, 龚德华,等. 国产高通量透析器在血液透析治疗中的有效性和安全性评估[J]. 肾脏病与透析肾移植杂志, 2012,21(6):524|529.

相似文献/References:

[1]林冲云,江 辉,邱 泱.福建省闽西地区维持性血液透析患者病因及贫血状况的多中心调查[J].福建医科大学学报,2015,49(06):373.
 LIN Chongyun,JIANG Hui,QIU Yang.Multicenter Investigation of Etiology and Anemia ofPatients with Maintenance Hemodialysis in Minxi Region[J].Journal of Fujian Medical University,2015,49(05):373.
[2]王四清,徐维瑭,邹丹敏.血液净化患者降脂治疗致急性横纹肌溶解症4例分析[J].福建医科大学学报,2017,51(02):130.

备注/Memo

备注/Memo:
作者简介: 罗来敏,男,副主任医师,医学硕士. Email: llm090626@163.com
更新日期/Last Update: 2017-10-30